Pay in 4 interest-free payments of $7.35 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
Despite the positive results, due to the limited number of included studies, further randomized controlled trials are needed to investigate the safety and efficacy of SGLT2i and GLP-1RAs as first-line treatment options for patients with T2DM at low cardiovascular disease risk, particularly when compared to metformin
Contact your healthcare provider if nausea prevents adequate hydration or nutrition for more than 24 hours
Do they understand the dosing instructions
The association between changes in adiposity during the first 20 weeks and subsequent MACE risk was assessed
US$ 24.87
US$ 23.30
US$ 28.81
US$ 29.61
